Mark Crowther: Iron Deficiency in Women Is Extraordinarily Common, Highly Symptomatic, and Still Widely Underrecognized
Mark Crowther, Distinguished University Professor and Chair, Department of Medicine at McMaster University, reposted from ASH on LinkedIn:
”Iron deficiency in women is extraordinarily common, highly symptomatic, and still widely underrecognized and undertreated.
It is also one of the easiest causes of significant morbidity to diagnose and treat—especially now, with multiple highly effective and accessible iron therapies that can deliver dramatic improvement in a short time.
Working closely with Michelle Sholzberg, her team, and many others, I’ve been honoured to help push this agenda through the Canadian Institute for the Transfer of Knowledge and beyond.
It is wonderful to see the American Society of Hematology on board!!
Testing for iron deficiency anemia is simple, reliable, and low-risk. If you think this might apply to you, go get tested.
There is essentially no downside, and the potential upside is life-changing.
A few weeks ago, I spoke with a healthcare professional who had never been asked about iron deficiency anemia or heavy menstrual bleeding.
A 10‑minute conversation led to diagnosis and treatment (for both) and, by her own account, has completely changed her life.”
Quoting American Society of Hematology (ASH)‘s post:
”During this Women’s History Month, ASH is highlighting the impact of iron deficiency in women.
Despite how common and clinically significant it is, iron deficiency has historically received too little attention in research and clinical care.
Women who menstruate or become pregnant are disproportionately affected during the reproductive years, when iron loss and requirements increase.
Iron deficiency can also cause symptoms even before anemia develops, including fatigue, weakness, hair thinning, low mood, and restless legs.
Greater awareness, earlier recognition, and continued research are needed to improve care and outcomes.
Share this post to help raise awareness and learn more.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers